COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,822 Articles (22,968 medRxiv, 8,854 bioRxiv)

Most recent first Previous |  Page 2284: Articles 22831-22840  | Next

Empirical transmission advantage of the D614G mutant strain of SARS-CoV-2
Leung, K., Pei, Y., Leung, G. M., Lam, T. T. Y., Wu, J. T.
10.1101/2020.09.22.20199810 — Posted: 2020-09-23
Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms
Linares, M., Perez Tanoira, R., Romanyk, J., Perez Garcia, F., Gomez-Herruz, P., Arroyo, T., Cuadros, J.
10.1101/2020.09.20.20198192 — Posted: 2020-09-23
Nature and dimensions of the cytokine storm and its attenuation by convalescent plasma in severe COVID-19
Bandopadhyay, P., D'Rozario, R., Lahiri, A., Sarif, J., Ray, Y., Paul, S. R., Roy, R., Maiti, R., Chaudhuri, K., Bagchi, S., Maiti, A., Parwez, M. M., Sharma Sarkar, B., Roy, D., Chakraborty, R., Vasudevan, J. S., Sharma, S., Biswas, D., Maiti, C., Saha, B., Bhattacharya, P., Pandey, R., Chatterjee, S., Paul, S., Ganguly, D.
10.1101/2020.09.21.20199109 — Posted: 2020-09-23
Early Humoral Response Correlates with Disease Severity and Outcomes in COVID-19 Patients
Hashem, A. M., Algaissi, A., Almahboub, S. A., Alfaleh, M. A., Abujamel, T. S., Alamri, S. S., Alluhaybi, K. A., Hobani, H. I., AlHarbi, R. H., Alsulaiman, R. M., ElAssouli, M.-Z., Hala, S., Alharbi, N. K., Alhabbab, R. Y., AlSaieedi, A. A., Abdulaal, W. H., Bukhari, A., AL-Somali, A. A., Alofi, F. S., Khogeer, A. A., Pain, A., Alkayyal, A. A., Almontashiri, N. A., Mahmoud, A. B., Li, X.
10.1101/2020.09.21.20198309 — Posted: 2020-09-23
Norwich COVID-19 Testing Initiative: feasibility project evaluation
Berger Gillam, T., Cole, J., Gharbi, K., Hitchcock, M., Edwards, D., Brabbs, T., Lipscombe, J., Davidson, R., Rushworth, S. A., Steel, N.
10.1101/2020.09.22.20199455 — Posted: 2020-09-23 Discussion: Onsite
Challenges and opportunities of the COVID-19 pandemic for perinatal mental health care: a mixed methods study of mental health care staff
Wilson, C. A., Dalton-Locke, C. A., Johnson, S., Simpson, A., Oram, S., Howard, L. M.
10.1101/2020.09.23.20199927 — Posted: 2020-09-23
Estimate of the actual number of COVID-19 cases from the analysis of deaths.
Etchenique, R., Quiroga, R.
10.1101/2020.09.21.20198416 — Posted: 2020-09-23 Discussion: Offsite
COVID-19 dynamics across the US: A deep learning study of human mobility and social behavior
Bhouri, M. A., Costabal, F. S., Wang, H., Linka, K., Peirlinck, M., Kuhl, E., Perdikaris, P.
10.1101/2020.09.20.20198432 — Posted: 2020-09-23
Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in ophthalmic patients
li, s., qiu, y., tang, l., wang, z., cao, w., xu, g., sun, x.
10.1101/2020.09.22.20198465 — Posted: 2020-09-23
Risk of adverse COVID-19 outcomes for people living with HIV: a rapid review and meta-analysis
Mellor, M., Bast, A., Jones, N., Roberts, N., Ordonez-Mena, J., Reith, A., Butler, C. C., Matthews, P. C., Dorward, J.
10.1101/2020.09.22.20199661 — Posted: 2020-09-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).